Brian Betts, MD

Hematologic Oncology

Brian Betts, MD

View full profile

Related Videos

New CAR T-Cell Therapy Shows Promise as ‘Magic Bullet’ for Patients with Relapsed/Refractory AML — Even After Transplant Video

New CAR T-Cell Therapy Shows Promise as ‘Magic Bullet’ for Patients with Relapsed/Refractory AML — Even After Transplant

A phase 1 clinical trial underway exclusively at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., is evaluating a new chimeric antigen receptor (CAR) T-cell therapy that could dramatically transform the treatment of relapsed ...

New CAR T Clinical Trials Underway at Roswell Park for Solid Tumor, Non-cancerous Diseases Video

New CAR T Clinical Trials Underway at Roswell Park for Solid Tumor, Non-cancerous Diseases

While the focus and promise of CAR T-cell therapies has long been on liquid tumors and hematologic malignancies, new trials under way at Roswell Park Comprehensive Cancer Center are expanding the applications of immunotherapy to include other diseases.

Meet the Team: Dr. Brian Betts Video

Meet the Team: Dr. Brian Betts

How aggressive graft versus host disease prophylaxis, nuanced donor selection and other approaches have led to critical gains in survival and cure rate and facilitate a safe and earlier return home.